X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2492) 2492
Publication (324) 324
Book Review (18) 18
Book Chapter (17) 17
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (1716) 1716
index medicus (1651) 1651
parasitology (945) 945
humans (875) 875
leishmania (813) 813
parasitic diseases (737) 737
leishmaniasis (663) 663
mice (622) 622
visceral leishmaniasis (594) 594
parasites (568) 568
microbiology (509) 509
immunology (484) 484
biochemistry & molecular biology (474) 474
female (454) 454
research article (390) 390
proteins (384) 384
mice, inbred balb c (383) 383
antiprotozoal agents - pharmacology (372) 372
cutaneous leishmaniasis (349) 349
analysis (348) 348
protozoan proteins - metabolism (345) 345
infectious diseases (342) 342
macrophages (330) 330
research (330) 330
promastigotes (324) 324
protozoan proteins - genetics (304) 304
health aspects (293) 293
molecular sequence data (293) 293
leishmaniasis, visceral - parasitology (287) 287
amino acid sequence (273) 273
gene expression (266) 266
donovani (261) 261
leishmania infantum (261) 261
male (253) 253
tropical medicine (253) 253
macrophages - parasitology (247) 247
in-vitro (237) 237
infection (234) 234
expression (230) 230
dogs (229) 229
medicine (228) 228
physiological aspects (224) 224
drug resistance (217) 217
biology (215) 215
genetic aspects (214) 214
enzymes (212) 212
leishmania - drug effects (211) 211
leishmaniasis, visceral - immunology (210) 210
infections (209) 209
cell biology (201) 201
leishmania infantum - drug effects (200) 200
leishmania infantum - genetics (196) 196
trypanosoma-cruzi (194) 194
metabolism (190) 190
identification (189) 189
amastigotes (184) 184
leishmania - genetics (180) 180
trypanosoma-brucei (180) 180
pharmacology & pharmacy (177) 177
tropical diseases (177) 177
kala-azar (175) 175
leishmania - metabolism (170) 170
life sciences (170) 170
multidisciplinary sciences (166) 166
vector-borne diseases (166) 166
science (160) 160
cells, cultured (158) 158
virulence (158) 158
leishmania donovani (156) 156
leishmania infantum - immunology (156) 156
leishmania infantum - metabolism (156) 156
dna (154) 154
cell line (153) 153
article (152) 152
chemotherapy (152) 152
apoptosis (147) 147
leishmaniasis - parasitology (147) 147
arctic medicine. tropical medicine (146) 146
infantum (146) 146
biochemistry (145) 145
leishmania donovani - drug effects (145) 145
drugs (142) 142
biology and life sciences (139) 139
leishmaniasis, visceral - veterinary (134) 134
leishmania donovani - genetics (133) 133
gene-expression (132) 132
leishmaniasis, visceral - drug therapy (132) 132
public aspects of medicine (132) 132
sequence alignment (132) 132
leishmania infantum - growth & development (131) 131
immune response (130) 130
leishmaniasis, cutaneous - parasitology (130) 130
cells (128) 128
cytokines (127) 127
nitric oxide (127) 127
immune-response (125) 125
phylogeny (125) 125
antiprotozoal agents - chemistry (124) 124
genes (124) 124
disease models, animal (123) 123
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, p. e0137976
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e81899
Journal Article
PloS one, ISSN 1932-6203, 2016, Volume 11, Issue 4, p. e0154101
During the last decade miltefosine (MIL) has been used as first-line treatment for visceral leishmaniasis in endemic areas with antimonial resistance, but a... 
TRANSLOCATION | TRANSPORTER | INDIAN VISCERAL LEISHMANIASIS | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | PAROMOMYCIN | IN-VITRO SELECTION | KALA-AZAR | DRUG-RESISTANCE | L.-DONOVANI | FAILURE | Parasitic Sensitivity Tests | Genome, Protozoan | Gene Expression Regulation | Selection, Genetic | Genotype | Phosphorylcholine - analogs & derivatives | Protozoan Proteins - genetics | Antiprotozoal Agents - pharmacology | Genetic Complementation Test | Life Cycle Stages - genetics | Carrier Proteins - genetics | Drug Resistance - genetics | Leishmania infantum - growth & development | Phenotype | Carrier Proteins - metabolism | Protozoan Proteins - metabolism | Biological Transport | Phosphorylcholine - pharmacology | Leishmania infantum - drug effects | High-Throughput Nucleotide Sequencing | Leishmania infantum - metabolism | Mutation | Leishmania infantum - genetics | Life Cycle Stages - drug effects | Drug resistance in microorganisms | Kala-azar | Leishmania | Physiological aspects | Genetic aspects | Research | Drug therapy | Promastigotes | Clinical isolates | Genomes | Parasites | Gene deletion | Drug resistance | Inactivation | Gene sequencing | Coupling (molecular) | Transfection | Clonal deletion | Acquired immune deficiency syndrome--AIDS | Parasitic diseases | Visceral leishmaniasis | Human immunodeficiency virus--HIV | Deletion | Deoxyribonucleic acid--DNA | Vector-borne diseases | Genomic analysis | Deactivation | Cloning | Stop codon | Exploration | Leishmaniasis | Amastigotes | Gene expression | Corrosion resistance | Miltefosine | Aberration | Intracellular | Laboratory animals | Transporter | Life Sciences | Microbiology and Parasitology | Parasitology | Acquired immune deficiency syndrome | Deoxyribonucleic acid | AIDS | HIV | DNA | Human immunodeficiency virus
Journal Article
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 07/2017, Volume 135, pp. 49 - 59
Journal Article
Amino Acids, ISSN 0939-4451, 2/2012, Volume 42, Issue 2, pp. 803 - 811
Journal Article